Sadik Kassim, Danaher CTO for Genomic Medicines and Vanessa Almendro, Danaher Head of Science & Technology Innovation discuss how the work developing a ‘CRISPR Cookbook’ will support the new Center for Pediatric CRISPR Cures. Danaher is proud to provide the essential manufacturing infrastructure for the new Center for Pediatric CRISPR Cures, launched by the Chan Zuckerberg Initiative and […]

Malvern Panalytical is proud to announce it is now an Associate Member of the International Pharmaceutical Aerosol Consortium on Regulation & Science (IPAC-RS) – an association that advances the science and regulatory standards of orally inhaled and nasal drug products (OINDPs) through collaboration, research, and development. This strategic partnership underpins Malvern Panalytical’s commitment to innovation […]

WOBURN, Mass. — Spear Bio, a biotechnology company pioneering homogeneous ultrasensitive immunoassay technology, today announced the commercial launch of its SPEAR UltraDetect™ immunoassay solution. It delivers unparalleled sensitivity, specificity, precision, and scalability for robust biomarker measurement. The initial launch includes four assays, targeting key neurology biomarkers: phosphorylated tau 231 (pTau231), phosphorylated tau 217 (pTau217), glial […]

Strengthens 90-year legacy of partnership between MilliporeSigma and WashU to accelerate scientific progress Strategic academic-industry alliance aims to build robust Research & Development talent pipeline Reinforces Mill ST. LOUIS — MilliporeSigma, the U.S. and Canada Life Science business of Merck KGaA, Darmstadt, Germany, a leading science and technology company, has signed a non-binding Memorandum of […]

Canada and United Kingdom – An international initiative will transform biologics and drug manufacturing through AI-driven multiplatform integration. The AI-optimised BALANCE (Bioreactor Automation for Learning and Adaptive Networked Control of Experiments) platform will leverage Nicoya’s real-time sensing and control systems, integrated with automation from Labman Automation, bioreactor technologies from CPI, and AI development by Basetwo to make bioprocessing smarter, more efficient, and […]

KITCHENER, Ontario & United Kingdom — An international initiative will transform biologics and drug manufacturing through AI-driven multiplatform integration. The AI-optimised BALANCE (Bioreactor Automation for Learning and Adaptive Networked Control of Experiments) platform will leverage Nicoya’s real-time sensing and control systems, integrated with automation from Labman Automation, bioreactor technologies from CPI, and AI development by […]

Genovis Expands License Agreement to Access Proprietary Enzyme Technology for Therapeutic Antibody-Drug Conjugate Development Genovis AB, a leading provider of innovative enzyme technologies, today announced an expansion of its license agreement with Thermo Fisher Scientific to gain access to proprietary enzyme technology to develop and manufacture antibody-drug conjugates (ADCs) intended for therapeutic use. This broadens […]

Tokyo, Japan — Spectrum Chemical Mfg. Corp — China and FUJIFILM Wako Pure Chemical Corporation (FUJIFILM Wako) have officially signed a strategic cooperation agreement, marking a significant milestone in expanding access to high-quality laboratory reagents in China. The signing ceremony took place at FUJIFILM Wako’s headquarters in Tokyo, Japan. Under the agreement, Spectrum China will become […]

Charlottesville, Virginia  — InBio, a global leader in high-quality, purified allergen proteins, and Beckman Coulter Life Sciences, a Danaher company and a global leader in laboratory automation and innovation, are collaborating to enhance the performance of basophil activation tests (BAT) for food allergy research. The collaboration integrates InBio’s Food Protein Standards and purified allergens with […]

New alliance delivers C-DIAM Multi-Omics Studio, a single-cell sequencing analysis platform, to Japanese labs, boosting biomarker and drug discovery research. Together, we are making it easier for Japan’s scientists to access the tools they need to unlock deeper insights and ultimately help more patients.” — Tristan Gill, CEO of Pythia Biosciences SAN DIEGO, CA, UNITED […]